Prostate cancer is cancer that occurs in the prostate. Prostate cancer is the most frequently diagnosed male cancer and the fifth leading cancer-related mortality rate in men around the world. In 2020, there were 1,414,249 newly diagnosed cases and 375,000 fatalities worldwide due to this illness. The majority of prostate tumors grow slowly, are low-grade, have a modest risk, and are not particularly aggressive.
Age - Men under the age of 40 are less likely to develop prostate cancer than older men, although the risk increases significantly after age 50. Men older than 65 are infected by prostate cancer in about 6 out of 10 cases
Race/ethnicity - A man's risk of having prostate cancer is more than doubled if his father or sibling has the condition
Gene changes - Inherited mutations in the BRCA1 or BRCA2 genes linked to an elevated risk of breast and ovarian cancer can also raise the risk of prostate cancer in men (especially mutations in BRCA2)
Prostate cancer risk is higher in men who have Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), a disorder caused by inherited gene alterations
Screening for prostate cancer - Prostate screening tests include:
1. Prostatectomy – includes the removal of affected tissues and lymph nodes of the prostate gland. This can be done by 2 techniques:
2. Radiation therapy includes -
3. Freezing or heating prostate tissue -
4. Chemotherapy
5. Immunotherapy
6. Targeted drug therapy
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.
2.
CAR-T cell therapy for cancer causes 'brain fog,' study shows
3.
Squeezing through tiny blood vessels may trigger melanoma cells to spread
4.
Fear of hair loss might cause some to reject cancer treatment
5.
Q&A: Why adolescents and young adults with cancer are falling behind
1.
Decoding the Future: Cancer Genomics and Radiomics in Oncology
2.
Understanding the Importance of Red Cell Distribution Width (RDW) in Blood Tests
3.
Can AI Become Our Oncologic Ally? A Look at Artificial Intelligence in Cancer Detection and Control
4.
Evolution of Cancer Care Through Developmental Therapeutics
5.
Oncology Drug Trends 2025: FDA Approvals, Immuno-Oncology, and Clinical Trial Insights
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part III
2.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
3.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation